AGL - Company ID 0001831097
The table below shows agilon health, inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $1.42B | $1.44B | $1.39B | $1.53B | $1.45B | $1.48B |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A |
agilon health, inc. reported annual revenue of $5.93B for fiscal year 2025. That is down 2.1% from $6.06B in fiscal 2024. Over the 7 fiscal years shown, annual revenue grew from $794.41M (FY 2019) to $5.93B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $54.23M |
| $56.20M |
| $56.28M |
| $65.96M |
| $63.12M |
| $69.61M |
| Operating income | $4.00M | -$131.27M | -$116.03M | -$22.11M | -$133.51M | -$43.34M |
| Income tax | $28.00K | -$331.00K | $62.00K | $196.00K | -$590.00K | $417.00K |
| Net income | $48.92M | -$110.21M | -$104.37M | $12.11M | -$117.61M | -$30.68M |
| EPS (diluted) | $2.94 | - | - | $0.73 | - | - |